REFERENCES
1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical
characteristics of 138 hospitalized patients with 2019 novel
coronavirus-ınfected pneumonia in Wuhan, China. JAMA - J Am Med Assoc.
2020;323(11).
2. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical
characteristics of coronavirus disease 2019 in China. N Engl J Med.
2020;382(18).
3. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin,
transmission and clinical therapies on coronavirus disease 2019
(COVID-19) outbreak- An update on the status. Vol. 7, Military Medical
Research. 2020.
4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020;395(10223).
5. Chen J. Pathogenicity and transmissibility of 2019-nCoV—A quick
overview and comparison with other emerging viruses. Microbes Infect.
2020;22(2).
6. Creager HM, Kumar A, Zeng H, Maines TR, Tumpey TM, Belser JA.
Infection and replication of ınfluenza virus at the ocular surface. J
Virol. 2018;92(7).
7. Vabret A, Mourez T, Dina J, Van Der Hoek L, Gouarin S, Petitjean J,
et al. Human coronavirus NL63, France. Emerg Infect Dis. 2005;
8. Martina BEE, Haagmans BL, Kuiken T, Fouchier RAM, Rimmelzwaan GF, Van
Amerongen G, et al. SARS virus infection of cats and ferrets. Nature.
2003;425(6961).
9. Yang Y-L, Qin P, Wang B, Liu Y, Xu G-H, Peng L, et al. Broad
cross-species ınfection of cultured cells by bat HKU2-related swine
acute diarrhea syndrome coronavirus and identification of its
replication in murine dendritic cells in vivo highlight its potential
for diverse interspecies transmission. J Virol. 2019;93(24).
10. Wu D, Tu C, Xin C, Xuan H, Meng Q, Liu Y, et al. Civets are equally
susceptible to experimental ınfection by two different severe acute
respiratory syndrome coronavirus isolates. J Virol. 2005;79(4).
11. Akpek EK, Gottsch JD. Immune of defense at the ocular surface. Eye.
2003;17(8).
12. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by
the novel coronavirus from Wuhan: An analysis based on decade-long
structural studies of SARS coronavirus. J Virol. 2020;94(7).
13. Senanayake PDS, Drazba J, Shadrach K, Milsted A, Rungger-Brandle E,
Nishiyama K, et al. Angiotensin II and its receptor subtypes in the
human retina. Investig Ophthalmol Vis Sci. 2007;
14. Wagner J, Danser AHJ, Derkx FHM, De Jong PTVM, Paul M, Mullins JJ,
et al. Demonstration of renin mRNA, angiotensinogen mRNA, and
angiotensin converting enzyme mRNA expression in the human eye: Evidence
for an intraocular renin-angiotensin system. Br J Ophthalmol. 1996;
15. Sun Y, Liu L, Pan X, Jing M. Mechanism of the action between the
SARS-CoV S240 protein and the ACE2 receptor in eyes. Int J Ophthalmol.
2006;
16. Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of
Ocular Findings of Patients with Coronavirus Disease 2019 (COVID-19) in
Hubei Province, China. JAMA Ophthalmol. 2020;
17. Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19)
affect the eyes? A review of coronaviruses and ocular ımplications in
humans and animals. Vol. 28, Ocular Immunology and Inflammation. 2020.
18. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in
tears and conjunctival secretions of patients with SARS-CoV-2 infection.
J Med Virol. 2020;92(6).
19. Zhou Y, Zeng Y, Tong Y, Chen C. Ophthalmologic evidence against the
interpersonal transmission of 2019 novel coronavirus through
conjunctiva. medRxiv. 2020;
20. Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W, et al. The infection
evidence of SARS-COV-2 in ocular surface : a single-center
cross-sectional study. medRxiv. 2020;(8197033356).
21. Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, et al. Ocular
manifestations and clinical characteristics of 534 cases of COVID-19 in
China: A cross-sectional study. medRxiv. 2020;
22. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical
characteristics of coronavirus disease 2019 in China. N Engl J Med.
2020;
23. Deng C, Yang Y, Chen H, Chen W, Chen Z, Ma K, et al. Ocular
dectection of SARS-CoV-2 in 114 cases of COVID-19 pneumonia in Wuhan,
China: an observational study. SSRN eLibrary. 2020;
24. Scalinci SZ, Trovato Battagliola E. Conjunctivitis can be the only
presenting sign and symptom of COVID-19. IDCases. 2020;20.
25. Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive
protein, procalcitonin, D-dimer, and ferritin in severe coronavirus
disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020;14.
26. Atum M, Boz AAE, Çakır B, Karabay O, Köroğlu M, Öğütlü A, et al.
Evaluation of conjunctival swab PCR results in patients with SARS-CoV-2
Infection. Ocul Immunol Inflamm. 2020;28(5).
27. Leonardi A, Rosani U, Brun P. Ocular surface expression of
SARS-CoV-2 receptors. Ocul Immunol Inflamm. 2020;28(5).
28. Katsifis GE, Moutsopoulos NM, Wahl SM. T Lymphocytes in Sjögren’s
syndrome: Contributors to and regulators of pathophysiology. Clin Rev
Allergy Immunol [Internet]. 2007;32(3):252–64. Available from:
https://doi.org/10.1007/s12016-007-8011-8
29. Lemp MA, Baudouin C, Baum J, Dogru M, Foulks GN, Kinoshita S, et al.
The definition and classification of dry eye disease: Report of the
definition and classification subcommittee of the international Dry Eye
WorkShop (2007). In: Ocular Surface. 2007.